Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
Public ClinicalTrials.gov record NCT00865280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Evaluator-Blinded, Phase 3 Study to Compare the Safety and Efficacy of PTK 0796 With Linezolid in the Treatment of Adults With Complicated Skin and Skin Structure Infection
Study identification
- NCT ID
- NCT00865280
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Paratek Pharmaceuticals Inc
- Industry
- Enrollment
- 143 participants
Conditions and interventions
Conditions
Interventions
- PTK 0796 Drug
- linezolid Drug
- moxifloxacin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 3, 2009
- Primary completion
- Apr 14, 2010
- Completion
- Apr 14, 2010
- Last update posted
- Mar 11, 2021
2009 – 2010
United States locations
- U.S. sites
- 7
- U.S. states
- 2
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Paratek Recruiting Site | Fountain Valley | California | 92708 | — |
| Parateck Recruiting Site | La Mesa | California | 91942 | — |
| Paratek Recruiting Site | Oceanside | California | 92056 | — |
| Paratek Recruiting Site | San Diego | California | 92114 | — |
| Paratek Recruiting Site | San Jose | California | 95154 | — |
| Parateck Recruiting Site | Columbus | Georgia | 31904 | — |
| Paratek Recruiting Site | Savannah | Georgia | 31406 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00865280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00865280 live on ClinicalTrials.gov.